top of page


Tripling down on GLP-1: The new triple receptor agonist drug as a weight-loss treatment.
The two pharmaceutical leaders in weight-loss drug race; Eli Lilly and Novo Nordisk developed and have been testing their triple receptor agonist drugs during clinical trials for weight loss. This new triple receptor agonist consists of glucagon peptide-1 receptor agonist (GLP-1 RA), glucose-dependent insulinotropic polypeptide (GIP), and glucagon. Eli Lilly is currently testing Retatrutide, an experimental triple receptor agonist drug for patients with obesity (without dia
Pique Choi, PhD
24 minutes ago4 min read


How Sleep Affects Your Immune System
Getting enough sleep is essential for maintaining good health, but many people underestimate its impact on the immune system. Sleep is not simply a time for the body to rest, it is an active biological process during which the body repairs tissues, regulates hormones, and strengthens its defenses against illness. Whether recovering from an infection or trying to stay healthy, consistently getting enough quality sleep can help the immune system function at its best. Why Sleep
Allison Tang
24 minutes ago3 min read


Advocating for Equitable Postpartum Pain Management for Black Mothers
In the childbirth cycle, the postpartum period begins after a woman gives birth and extends through the first 12 weeks after delivery. During this time, mothers recover from childbirth and may experience varying levels of uterine, perineal, abdominal incision, and breast pain (American College of Obstetricians & Gynecologist [ACOG], 2020). Researchers have found that Black women in the United States experience greater disparities in postpartum pain management compared to Whit
beachcopeland
1 day ago5 min read
bottom of page

